Sino Biopharmaceutical Limited (FRA:SMZ1)
Germany flag Germany · Delayed Price · Currency is EUR
0.8994
+0.0376 (4.36%)
At close: Sep 30, 2025

Sino Biopharmaceutical Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
15,9407,2447,39410,13511,54814,859
Upgrade
Market Cap Growth
140.05%-2.02%-27.05%-12.23%-22.28%-4.98%
Upgrade
Enterprise Value
16,4858,0167,68810,82012,86915,405
Upgrade
Last Close Price
0.900.390.380.510.550.70
Upgrade
PE Ratio
34.6415.6424.8529.375.7142.82
Upgrade
PS Ratio
4.391.902.212.873.115.02
Upgrade
PB Ratio
2.931.281.521.972.215.29
Upgrade
P/TBV Ratio
4.431.781.962.592.847.22
Upgrade
P/FCF Ratio
22.839.6811.6014.8822.8430.42
Upgrade
P/OCF Ratio
20.028.289.5511.9315.5522.28
Upgrade
EV/Sales Ratio
4.492.102.303.073.465.20
Upgrade
EV/EBITDA Ratio
19.768.799.4512.7517.0521.73
Upgrade
EV/EBIT Ratio
24.0510.4411.0814.8120.0730.02
Upgrade
EV/FCF Ratio
23.6110.7112.0615.8825.4631.54
Upgrade
Debt / Equity Ratio
0.260.230.330.370.330.63
Upgrade
Debt / EBITDA Ratio
1.731.391.972.222.212.48
Upgrade
Debt / FCF Ratio
-1.722.542.813.363.64
Upgrade
Asset Turnover
0.430.450.410.420.500.56
Upgrade
Inventory Turnover
2.832.442.312.102.792.93
Upgrade
Quick Ratio
1.141.110.901.151.381.87
Upgrade
Current Ratio
1.361.261.051.291.532.08
Upgrade
Return on Equity (ROE)
15.40%11.82%12.12%11.94%55.25%20.20%
Upgrade
Return on Assets (ROA)
5.07%5.62%5.33%5.40%5.37%6.05%
Upgrade
Return on Capital (ROIC)
6.55%7.02%6.60%6.60%6.69%7.79%
Upgrade
Return on Capital Employed (ROCE)
11.50%12.70%13.30%12.30%10.30%11.30%
Upgrade
Earnings Yield
2.89%6.39%4.02%3.40%17.51%2.33%
Upgrade
FCF Yield
4.38%10.33%8.62%6.72%4.38%3.29%
Upgrade
Dividend Yield
1.15%2.21%1.48%2.80%1.65%1.10%
Upgrade
Payout Ratio
47.69%52.76%27.13%49.84%6.42%42.84%
Upgrade
Buyback Yield / Dilution
2.10%1.26%2.57%1.38%-2.57%0.06%
Upgrade
Total Shareholder Return
3.24%3.47%4.04%4.18%-0.92%1.16%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.